Changes in UK drug-pricing scheme could impede access, group warns

05/8/2013 | PharmaTimes (U.K.)

A U.K. government proposal to use value-based pricing for pharmaceuticals could make it more difficult for patients to afford treatment, think tank 2020health says in a new report. The group calls for allowing drug companies to set their own prices and adjust old drug prices to ensure affordability.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY